Interim analysis of an open-label randomized controlled trial evaluating nasal irrigations in non-hospitalized patients with coronavirus disease 2019

Int Forum Allergy Rhinol. 2020 Dec;10(12):1325-1328. doi: 10.1002/alr.22703. Epub 2020 Oct 20.

Authors

Affiliations

¹ Department of Otolaryngology-Head and Neck Surgery, Vanderbilt University Medical Center, Nashville, TN.
² Vanderbilt University School of Medicine, Nashville, TN.
³ Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN.
⁴ Department of Medicine, Division of Microbiology and Infectious Disease, Vanderbilt University School of Medicine, Nashville, TN.

No abstract available

Keywords: COVID-19; coronavirus; irrigation; nasal; saline.

Publication types

Randomized Controlled Trial
Research Support, N.I.H., Extramural

MeSH terms

Adult
COVID-19 / pathology
COVID-19 / therapy*
Female
Humans
Male
Middle Aged
Nasal Lavage*
SARS-CoV-2
Saline Solution, Hypertonic / administration & dosage
Surface-Active Agents / administration & dosage
Treatment Outcome

Substances

Saline Solution, Hypertonic
Surface-Active Agents

Grants and funding

R21 AI142321/AI/NIAID NIH HHS/United States